Zhejiang Hisoar Pharmaceutical Co Ltd - Asset Resilience Ratio

Latest as of September 2025: 0.20%

Zhejiang Hisoar Pharmaceutical Co Ltd (002099) has an Asset Resilience Ratio of 0.20% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

CN¥14.71 Million
≈ $2.15 Million USD Cash + Short-term Investments

Total Assets

CN¥7.28 Billion
≈ $1.06 Billion USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2003–2024)

This chart shows how Zhejiang Hisoar Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. Check Zhejiang Hisoar Pharmaceutical Co Ltd PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Zhejiang Hisoar Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 002099 company net worth.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥14.71 Million 0.2%
Total Liquid Assets CN¥14.71 Million 0.20%

Asset Resilience Insights

  • Limited Liquidity: Zhejiang Hisoar Pharmaceutical Co Ltd maintains only 0.20% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Zhejiang Hisoar Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio

Compare Zhejiang Hisoar Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Takeda Pharmaceutical Company Limited
F:TKDA
Drug Manufacturers - Specialty & Generic 0.69%
Shandong Buchang Pharmaceuticals Co Ltd
SHG:603858
Drug Manufacturers - Specialty & Generic 3.47%
Beijing Sun Novo Pharmaceutical Research Co Ltd
SHG:688621
Drug Manufacturers - Specialty & Generic 2.04%
Guizhou Xinbang Pharmaceutical Co Ltd
SHE:002390
Drug Manufacturers - Specialty & Generic 0.01%
Guangdong Lifestrong Pharmacy Co. Ltd.
SHE:301111
Drug Manufacturers - Specialty & Generic 7.85%
Jw Pharmac
KO:001060
Drug Manufacturers - Specialty & Generic 3.65%
Kamada
TA:KMDA
Drug Manufacturers - Specialty & Generic 0.00%
Samjin Pharm
KO:005500
Drug Manufacturers - Specialty & Generic 0.25%

Annual Asset Resilience Ratio for Zhejiang Hisoar Pharmaceutical Co Ltd (2003–2024)

The table below shows the annual Asset Resilience Ratio data for Zhejiang Hisoar Pharmaceutical Co Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 0.60% CN¥45.03 Million
≈ $6.59 Million
CN¥7.46 Billion
≈ $1.09 Billion
+0.49pp
2021-12-31 0.12% CN¥9.48 Million
≈ $1.39 Million
CN¥8.02 Billion
≈ $1.17 Billion
-2.01pp
2018-12-31 2.13% CN¥150.00 Million
≈ $21.95 Million
CN¥7.04 Billion
≈ $1.03 Billion
+1.46pp
2017-12-31 0.67% CN¥50.00 Million
≈ $7.32 Million
CN¥7.47 Billion
≈ $1.09 Billion
+0.67pp
2014-12-31 0.00% CN¥119.75K
≈ $17.52K
CN¥4.17 Billion
≈ $609.83 Million
-0.04pp
2011-12-31 0.04% CN¥561.04K
≈ $82.10K
CN¥1.44 Billion
≈ $210.01 Million
-0.02pp
2006-12-31 0.05% CN¥500.00K
≈ $73.17K
CN¥921.93 Million
≈ $134.91 Million
-0.08pp
2005-12-31 0.14% CN¥800.00K
≈ $117.07K
CN¥576.72 Million
≈ $84.39 Million
-0.01pp
2004-12-31 0.15% CN¥576.32K
≈ $84.33K
CN¥387.38 Million
≈ $56.69 Million
-1.14pp
2003-12-31 1.29% CN¥4.67 Million
≈ $683.58K
CN¥362.38 Million
≈ $53.03 Million
--
pp = percentage points

About Zhejiang Hisoar Pharmaceutical Co Ltd

SHE:002099 China Drug Manufacturers - Specialty & Generic
Market Cap
$1.31 Billion
CN¥8.92 Billion CNY
Market Cap Rank
#7675 Global
#1690 in China
Share Price
CN¥5.51
Change (1 day)
+1.10%
52-Week Range
CN¥4.98 - CN¥8.83
All Time High
CN¥11.31
About

Zhejiang Hisoar Pharmaceutical Co., Ltd. engages in the manufacture of pharmaceutical products and dyes in China and internationally. The company offers antibiotics, cardiovascular, hypoglycemic, fine chemicals, formulations, intermediates, and other products. It also provides dyestuff, and intermediates of dyestuff and pigment; and manufactures environmental protection related equipment, medical… Read more